EBV is the most distinct etiological agent for the development of nasopharyngeal carcinoma (NPC), a type of cancer in which STAT3 activation or overexpression is associated with more than 75% of tumors in regions where EBV is endemic [119]. The gene discussed is STAT3; the disease is nasopharyngeal carcinoma.